Paper41219266
Recovery of glioblastoma cells derived from patients after a decade of cryopreservation for drug response studies.
Khotchawan W and 4 others. Sci Rep, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Recovery of glioblastoma cells derived from patients after a decade of cryopreservation for drug response studies. Papers, record 41219266. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41219266
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recovery of glioblastoma cells derived from patients after a decade of cryopreservation for drug response studies.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioblastoma | Major topic |
| Cryopreservation | Major topic |
| Brain Neoplasms | Major topic |
| Humans | |
| Temozolomide | |
| Cell Proliferation | |
| Cell Survival | |
| Drug Screening Assays, Antitumor | |
| Spheroids, Cellular | |
| Tumor Cells, Cultured | |
| Cell Line, Tumor | |
| Cell Culture Techniques |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R016633028 | Mahidol University | PubMed |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38474286 | Glioblastoma: An Update in Pathology, Molecular Mechanisms and Biomarkers. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474286 | PubMed |
| 2 | 34595478 | Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures. | Neurooncol Adv | 2021 | https://conductscience.org/library/papers/34595478 | PubMed |
| 3 | 35922758 | Characterization and comparison of human glioblastoma models. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35922758 | PubMed |
| 4 | 27651158 | Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesis. | Tumour Biol | 2016 | https://conductscience.org/library/papers/27651158 | PubMed |
| 5 | 34114695 | G protein-coupled receptors can control the Hippo/YAP pathway through Gq signaling. | FASEB J | 2021 | https://conductscience.org/library/papers/34114695 | PubMed |
| 6 | 39118096 | Glioma actively orchestrate a self-advantageous extracellular matrix to promote recurrence and progression. | BMC Cancer | 2024 | https://conductscience.org/library/papers/39118096 | PubMed |
| 7 | 33649855 | Corilagin induces human glioblastoma U251 cell apoptosis by impeding activity of (immuno)proteasome. | Oncol Rep | 2021 | https://conductscience.org/library/papers/33649855 | PubMed |
| 8 | 33788709 | Understanding the Biological Basis of Glioblastoma Patient-derived Spheroids. | Anticancer Res | 2021 | https://conductscience.org/library/papers/33788709 | PubMed |
| 9 | 29348601 | Exclusion from spheroid formation identifies loss of essential cell-cell adhesion molecules in colon cancer cells. | Sci Rep | 2018 | https://conductscience.org/library/papers/29348601 | PubMed |
| 10 | 37508520 | Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype. | Cells | 2023 | https://conductscience.org/library/papers/37508520 | PubMed |
| 11 | 28241049 | Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity. | PLoS One | 2017 | https://conductscience.org/library/papers/28241049 | PubMed |
| 12 | 40011944 | Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies. | Mol Cancer | 2025 | https://conductscience.org/library/papers/40011944 | PubMed |
| 13 | 34178955 | Heterotypic Tumor Spheroids in Agitation-Based Cultures: A Scaffold-Free Cell Model That Sustains Long-Term Survival of Endothelial Cells. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/34178955 | PubMed |
| 14 | 33762015 | Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives. | Stem Cell Res Ther | 2021 | https://conductscience.org/library/papers/33762015 | PubMed |
| 15 | 38678014 | A vascularized breast cancer spheroid platform for the ranked evaluation of tumor microenvironment-targeted drugs by light sheet fluorescence microscopy. | Nat Commun | 2024 | https://conductscience.org/library/papers/38678014 | PubMed |
| 16 | 33665625 | Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening. | STAR Protoc | 2021 | https://conductscience.org/library/papers/33665625 | PubMed |
| 17 | 18835895 | The role of extracellular matrix in glioma invasion: a cellular Potts model approach. | Biophys J | 2008 | https://conductscience.org/library/papers/18835895 | PubMed |
| 18 | 22863277 | Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. | Cell | 2012 | https://conductscience.org/library/papers/22863277 | PubMed |
| 19 | 33585240 | Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments. | Front Oncol | 2020 | https://conductscience.org/library/papers/33585240 | PubMed |
| 20 | 33107762 | Optimization of Viable Glioblastoma Cryopreservation for Establishment of Primary Tumor Cell Cultures. | Biopreserv Biobank | 2021 | https://conductscience.org/library/papers/33107762 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985493 | Three-dimensional in vitro models for assessing temozolomide sensitivity in glioblastoma. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42985493 | PubMed |
| 41971164 | Recovery and Expansion of Patient-Derived Glioblastoma Cells After Long-term Cryopreservation. | Bio Protoc | 2026 | https://conductscience.org/library/papers/41971164 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
| YAP1 | 10413 | PubTator's text mining | https://conductscience.org/library/genes/10413 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41219266
GET https://conductscience.org/api/papers/v1/41219266/references?page=2